Cysteine proteases, such as cathepsins, are known to be overexpressed in various cancers. These proteases are involved in the degradation of ECM components, similar to MMPs and serine proteases. Cathepsins also participate in the modulation of the tumor microenvironment, influencing processes such as inflammation and immune response. Their overexpression is often correlated with increased tumor aggressiveness and metastasis.
